Table 1 Baseline demographics and preoperative workup of all patients
From: 18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer
Variable | N = 86 |
|---|---|
Median age, years [range] | 63 [38–82] |
Male Gender (%) | 66 (77) |
Active smoking (%) | 38 (44) |
ASA class (%) | |
1–2 | 61 (71) |
3–4 | 25 (29) |
Tumor location (%) | |
Upper third | 3 (4) |
Middle third | 27 (31) |
Distal third | 29 (34) |
Gastroesophageal junction | 27 (31) |
Clinical T stage (cT) | |
cT1–2 | 21 (24) |
cT3–4 | 63 (73) |
Missing data | 2 (2) |
Clinical N stage (cN) | |
cN0 | 33 (38) |
cN+ | 49 (57) |
Missing data | 4 (5) |
Tumor histology | |
Adenocarcinoma | 46 (53) |
Squamous cell carcinoma | 40 (47) |
Preoperative workup | |
CT | 86 (100) |
EUS | 78 (91) |
EUS non-obstructive lesion | 73 (85) |
18F- FDG PET/CT | 86 (100) |
18F- FDG PET/CT -avid lesion | 81 (94) |
Neoadjuvant treatment | 71 (82) |
Operative approach | |
Transthoracic (Lewis) | 65 (76) |
Three-field (McKeown) | 19 (22) |
Transhiatal | 2 (2) |